$12.8M Settlement Reached in KV Pharmaceuticals Securities Class Action Lawsuit

This is a settlement for the KV Pharmaceutical Company lawsuit.

- by

New York, NY: A $12.8 million settlement has been reached in a securities class action pending against the bankrupt KV Pharmaceutical Co. Preliminary approval was given in January from Judge Carol Jackson of the U.S. District Court for the Eastern District of Missouri.

Lead plaintiffs, Norfolk County Retirement System and the State-Boston Retirement System, and the rest of the class alleged KV made misstatements and omissions regarding its compliance with the FDA and with good manufacturing practices. And, therefore, the plaintiffs claimed, they purchased the defendants securities at artificially inflated prices and "were damaged as a result."

The lawsuit further claims that in 2008 KV ended production of much of its product line after issuing a recall of its painkillers due to the tablets being oversized.

A settlement hearing is scheduled for April 23.

The settlement with the bankrupt KV Pharmaceutical Co. entity will not affect the restructured KV Pharmaceutical, which emerged from Chapter 11 bankruptcy in September, according to the St. Louis Post-Dispatch.

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please fill in our form on the right.

Add Your Comment on This Issue

Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment:
Request Legal Help